GO:0055071 manganese ion homeostasis: Metal Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055071 manganese ion homeostasis is the biological process that maintains a steady internal concentration of manganese ions (Mn2+) within cells and organisms.
• Manganese is an essential trace metal that serves as a cofactor for enzymes including mitochondrial superoxide dismutase (SOD2), arginase, and glutamine synthetase, and it is required for normal development and antioxidant defense.
• Disruption of manganese homeostasis is linked to neurodegenerative diseases such as manganism, Alzheimer's disease, and Parkinson's disease, as well as to Golgi dysfunction and metabolic disorders.
• Key genes involved in manganese homeostasis include SLC30A10, SLC39A8, SLC39A14, ATP13A2, SPCA1 (ATP2C1), and MTF1, which mediate manganese uptake, efflux, and intracellular trafficking.
• Manganese homeostasis intersects with iron and other metal ion homeostatic networks, and its dysregulation can drive oxidative stress and ferroptosis-like cell death.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are powerful tools for dissecting the causal roles of manganese homeostasis genes in health and disease.
Description
Manganese ion homeostasis (GO:0055071) refers to any process involved in the maintenance of an internal steady state of manganese ions within an organism or cell. Manganese is an essential trace element that acts as a cofactor for a wide range of enzymes, including mitochondrial superoxide dismutase (SOD2), arginase, and glutamine synthetase, and it plays critical roles in antioxidant defense, neurotransmitter synthesis, and bone formation. Because both manganese deficiency and overload are detrimental, cells have evolved sophisticated transport and storage mechanisms to keep cytosolic and organellar manganese concentrations within a narrow physiological range. Research into manganese ion homeostasis has gained momentum because of its strong association with human disease. Inherited mutations in genes such as SLC30A10, SLC39A8, and SLC39A14 cause severe manganese-related disorders, including hypermanganesemia with dystonia, polycythemia, and cirrhosis. Moreover, manganese dyshomeostasis has been implicated in neurodegenerative conditions such as Parkinson's disease and Alzheimer's disease, where it may exacerbate oxidative stress and protein aggregation. At the cellular level, the Golgi apparatus and mitochondria are key organelles for manganese handling, and their dysfunction can propagate metal imbalance. For researchers, understanding manganese ion homeostasis requires integrating metal transport, organellar biology, and disease genetics. This article provides a structured overview of the ontology term, its core mechanisms, the genes and proteins involved, and the experimental models and methods used to study it, with a focus on CRISPR-based approaches for functional validation.
manganese ion homeostasis At A Glance
| GO ID | GO:0055071 |
|---|---|
| GO term | manganese ion homeostasis |
| Ontology | biological_process |
| Synonym | manganese homeostasis |
| Definition | Any process involved in the maintenance of an internal steady state of manganese ions within an organism or cell. |
| Major function | Maintains physiological manganese concentrations for enzyme cofactor utilization, antioxidant defense, and prevention of manganese toxicity. |
| Key organelles | Golgi apparatus, mitochondria, and endolysosomal system. |
| Related metals | Iron, zinc, and calcium homeostasis pathways intersect with manganese handling. |
| Disease relevance | Manganese dyshomeostasis is linked to neurodegenerative diseases, liver cirrhosis, and metabolic disorders. |
What Is GO:0055071?
GO:0055071 manganese ion homeostasis is defined as any process involved in the maintenance of an internal steady state of manganese ions within an organism or cell. In practice, this includes the regulated uptake of manganese from the extracellular environment, its intracellular sequestration into organelles such as the Golgi and mitochondria, its utilization as an enzyme cofactor, and its export or detoxification when in excess. The term encompasses both systemic manganese balance (e.g., intestinal absorption, hepatic excretion, and biliary elimination) and cellular manganese homeostasis (e.g., transporter-mediated fluxes across the plasma membrane and organellar membranes).
Why Is manganese ion homeostasis Important in Cell Biology?
Manganese ion homeostasis is critically important because manganese is both essential and potentially toxic. As a cofactor for enzymes such as SOD2 and arginase, manganese supports mitochondrial antioxidant defense and nitrogen metabolism. However, excess manganese accumulates in the basal ganglia and can cause manganism, a Parkinson-like syndrome, while manganese deficiency impairs growth, bone formation, and antioxidant capacity. The Golgi apparatus is a major intracellular manganese store, and its dysfunction contributes to diseases ranging from cancer to neurodegeneration. Therefore, understanding the molecular players and regulatory mechanisms of manganese homeostasis is essential for developing therapies for metal-related disorders.
• Manganese is an essential cofactor for SOD2, arginase, and glutamine synthetase, linking homeostasis to oxidative stress defense and nitrogen metabolism.
• Inherited mutations in SLC30A10, SLC39A8, and SLC39A14 cause severe manganese-related diseases, including dystonia and cirrhosis.
• Manganese overload is associated with manganism and contributes to Parkinson's disease pathology.
• Golgi manganese homeostasis is required for proper protein glycosylation and sorting, and its disruption is linked to human diseases.
• Manganese homeostasis intersects with iron metabolism, and imbalance can promote ferroptosis-like cell death.
• Bacterial manganese homeostasis is important for virulence and stress resistance, making it a target for antimicrobial strategies.
• Manganese-based nanomaterials are being explored for biomedical applications, including wound healing and antimicrobial therapy.
• CRISPR screening can identify novel regulators of manganese homeostasis, accelerating therapeutic target discovery.
What Happens During manganese ion homeostasis?
Manganese uptake across the plasma membrane
In simple terms: Cells take in manganese from the outside through specialized transporter proteins.
Manganese enters cells primarily via divalent metal transporters. SLC39A8 (ZIP8) and SLC39A14 (ZIP14) are well-characterized manganese importers that mediate uptake from the extracellular milieu. SLC39A8 is also implicated in manganese-dependent glycosylation, and its mutations cause a congenital disorder of glycosylation. In bacteria such as Bacillus subtilis, manganese uptake is mediated by the MntH transporter and is tightly regulated by the MntR repressor. Uptake is the first step in maintaining intracellular manganese levels and is subject to feedback regulation.
Intracellular sequestration and organellar storage
In simple terms: Once inside, manganese is stored in organelles like the Golgi and mitochondria to keep the cytoplasm safe.
The Golgi apparatus serves as a major intracellular manganese store and is enriched in manganese-dependent enzymes involved in glycosylation and sulfation. The secretory pathway calcium ATPase SPCA1 (ATP2C1) transports manganese into the Golgi lumen, and its dysfunction alters Golgi manganese content and pH homeostasis. Mitochondria also accumulate manganese, where it is required for SOD2 activity; however, excessive mitochondrial manganese can impair oxidative phosphorylation. Lysosomes and endosomes participate in manganese trafficking and recycling, contributing to overall cellular homeostasis.
Manganese efflux and detoxification
In simple terms: When manganese levels get too high, cells pump it out or store it safely to avoid toxicity.
Manganese efflux is mediated by SLC30A10 (ZnT10), a plasma membrane transporter that exports manganese from cells. Loss-of-function mutations in SLC30A10 cause hypermanganesemia with dystonia, polycythemia, and cirrhosis, highlighting its critical role in manganese detoxification. ATP13A2 (PARK9) is a lysosomal transporter that may also contribute to manganese efflux and is linked to Kufor-Rakeb syndrome, a form of early-onset parkinsonism. In addition, metal-binding proteins such as metallothioneins can sequester manganese, although their role in manganese homeostasis is less well defined than for zinc and copper.
Systemic manganese balance
In simple terms: The whole body regulates manganese through absorption in the gut and excretion in the liver.
At the organismal level, manganese homeostasis involves intestinal absorption, distribution via the bloodstream, hepatic uptake, and biliary excretion. The liver is the central organ for manganese elimination, and impaired biliary excretion leads to manganese accumulation in the brain. Dietary manganese is absorbed primarily in the small intestine, and its bioavailability is influenced by other metals such as iron and zinc. Systemic manganese balance is essential for normal development and neurological function, and its disruption can cause both deficiency and toxicity syndromes.
Regulation by metal-responsive transcription factors
In simple terms: Cells adjust manganese transporters in response to changing manganese levels using specialized sensor proteins.
In bacteria, the MntR repressor senses manganese and regulates the expression of uptake systems such as MntH. In mammalian cells, metal-responsive transcription factor 1 (MTF1) regulates genes involved in metal homeostasis, including some manganese transporters, although its role in manganese-specific regulation is still being defined. Post-translational mechanisms, such as protein trafficking and degradation of transporters, also contribute to manganese homeostasis. These regulatory layers ensure that manganese concentrations are maintained within a narrow physiological range despite fluctuating dietary intake and cellular demands.
Key Genes Involved in GO:0055071 manganese ion homeostasis
The following genes and proteins are central to manganese ion homeostasis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC30A10 | Manganese efflux transporter at the plasma membrane | Mutations cause hypermanganesemia with dystonia, polycythemia, and cirrhosis; target for liver and brain manganese studies. |
| SLC39A8 | Manganese uptake transporter (ZIP8) | Mutations cause congenital disorder of glycosylation; links manganese to Golgi function. |
| SLC39A14 | Manganese uptake transporter (ZIP14) | Mutations cause childhood-onset parkinsonism-dystonia; mediates hepatic manganese uptake. |
| ATP13A2 | Lysosomal transporter involved in manganese efflux | Mutations cause Kufor-Rakeb syndrome; linked to Parkinson's disease. |
| ATP2C1 | Golgi manganese/calcium pump (SPCA1) | Regulates Golgi manganese content; mutations cause Hailey-Hailey disease. |
| MTF1 | Metal-responsive transcription factor | Regulates metal homeostasis genes; potential regulator of manganese transporters. |
| SOD2 | Mitochondrial manganese superoxide dismutase | Requires manganese as cofactor; key antioxidant enzyme. |
| ARG1 | Arginase 1, manganese-dependent enzyme | Liver arginase; links manganese to urea cycle. |
| GLS | Glutamine synthetase, manganese-dependent enzyme | Brain glutamine synthetase; important for neurotransmitter cycling. |
| MntH | Bacterial manganese uptake transporter | Model for manganese transport in Bacillus subtilis. |
| MntR | Bacterial manganese-responsive repressor | Regulates MntH expression; paradigm for metal sensing. |
| ZIP8 (SLC39A8) | Manganese and zinc importer | Polymorphisms linked to manganese levels and metabolic traits. |
| ZIP14 (SLC39A14) | Manganese and iron importer | Deletion causes manganese accumulation in brain. |
| ZnT10 (SLC30A10) | Manganese exporter | Loss causes manganese toxicity; target for gene therapy. |
| PARK9 (ATP13A2) | Lysosomal manganese transporter | Neuroprotective role; linked to Parkinson's disease. |
| SPCA1 (ATP2C1) | Golgi manganese pump | Maintains Golgi manganese for glycosylation. |
| MT1/MT2 | Metallothioneins | Metal-binding proteins; may modulate manganese toxicity. |
| DMT1 (SLC11A2) | Divalent metal transporter | Can transport manganese; links iron and manganese homeostasis. |
How Is manganese ion homeostasis Regulated?
Manganese ion homeostasis is regulated at multiple levels. In bacteria, the MntR repressor senses intracellular manganese and represses the expression of the MntH uptake transporter when manganese is sufficient. In mammalian cells, the metal-responsive transcription factor MTF1 can modulate the expression of genes involved in metal handling, although its direct role in manganese homeostasis is still under investigation. Post-transcriptional and post-translational mechanisms, including transporter trafficking, ubiquitination, and degradation, also control manganese flux. Additionally, cellular manganese levels are influenced by interactions with other metals such as iron and zinc, which can compete for shared transporters. The Golgi apparatus and mitochondria act as buffering organelles, and their pH and ion homeostasis are tightly linked to manganese regulation.
manganese ion homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC30A10 | Hypermanganesemia with dystonia, polycythemia, and cirrhosis | Liver-specific knockout mouse; patient-derived iPSC hepatocytes. |
| SLC39A14 | Childhood-onset parkinsonism-dystonia | Knockout mouse; neuronal cell lines with point mutations. |
| ATP13A2 | Kufor-Rakeb syndrome (early-onset parkinsonism) | Knockout dopaminergic neurons; lysosomal trafficking assays. |
| ATP2C1 | Hailey-Hailey disease | Keratinocyte knockout models; Golgi manganese imaging. |
| SLC39A8 | Congenital disorder of glycosylation | Patient fibroblasts; knock-in mice with patient mutations. |
Manganese dyshomeostasis in neurodegenerative diseases
Manganese accumulates in the basal ganglia and can cause manganism, a Parkinson-like syndrome characterized by dystonia and gait disturbances. Mutations in SLC30A10 and SLC39A14 lead to inherited forms of manganese-induced parkinsonism-dystonia, demonstrating a direct link between manganese homeostasis and neurodegeneration. In sporadic Parkinson's disease, manganese may exacerbate oxidative stress and alpha-synuclein aggregation, although the causal role is still debated. Alzheimer's disease has also been associated with altered metal homeostasis, including manganese, which may contribute to amyloid-beta pathology.
Golgi dysfunction and manganese-related disorders
The Golgi apparatus is a major manganese store, and its homeostasis is essential for protein glycosylation and sorting. Mutations in ATP2C1 (SPCA1), which pumps manganese into the Golgi, cause Hailey-Hailey disease, a skin blistering disorder. SLC39A8 mutations impair manganese uptake into the Golgi and cause a congenital disorder of glycosylation with developmental delay. These examples highlight the importance of organellar manganese homeostasis in human health.
Manganese and metabolic/liver diseases
SLC30A10 deficiency causes hypermanganesemia with dystonia, polycythemia, and chronic liver disease, often leading to cirrhosis. The liver is the primary organ for manganese excretion, and impaired biliary excretion results in systemic manganese overload. Manganese also influences glucose metabolism and insulin signaling, and altered manganese levels have been observed in diabetes. Understanding manganese homeostasis in the liver is therefore critical for developing treatments for these metabolic disorders.
Manganese in infection and immunity
Pathogenic bacteria require manganese for virulence and stress resistance, and their manganese uptake systems are potential antibiotic targets. In humans, manganese is important for immune cell function, and manganese-based nanomaterials are being explored for antimicrobial and immunomodulatory therapies. For example, biodegradable oxygen-evolving metalloantibiotics have shown efficacy against orthopaedic biofilm infections. These applications underscore the broad biomedical relevance of manganese homeostasis.
From manganese ion homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC30A10 cause manganese accumulation and toxicity? | SLC30A10 knockout cell line (e.g., HepG2 or iPSC-derived hepatocytes). |
| How do disease-associated point mutations in SLC39A14 affect manganese transport? | Knock-in cell lines expressing mutant SLC39A14. |
| Can restoring ATP13A2 function rescue lysosomal manganese overload? | ATP13A2 knock-in or overexpression in patient-derived neurons. |
| What is the role of Golgi manganese in glycosylation? | ATP2C1 knockout or knockdown in HeLa or keratinocytes. |
| Which genes regulate manganese homeostasis in a genome-wide manner? | CRISPR knockout library screening with manganese-sensitive reporters. |
| Does overexpression of SLC30A10 protect against manganese toxicity? | SLC30A10 overexpression in neuronal or hepatic cell lines. |
How to Study the manganese ion homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ICP-MS | Total manganese concentration in cells or tissues | Quantifying manganese overload in knockout models. |
| RNA-seq | Transcriptional changes in manganese homeostasis genes | Identifying compensatory responses to manganese stress. |
| CRISPR screening | Genes required for manganese homeostasis | Genome-wide discovery of novel regulators. |
| Fluorescent manganese sensors | Real-time intracellular manganese dynamics | Live-cell imaging of organellar manganese. |
| 54Mn uptake assay | Rate of manganese transport | Functional characterization of transporters. |
| Seahorse assay | Mitochondrial respiration | Assessing manganese effects on oxidative phosphorylation. |
| Golgi pH imaging | Golgi pH and ion homeostasis | Linking manganese transport to Golgi function. |
| Yeast complementation | Functional conservation of manganese transporters | Testing human disease mutations in yeast. |
Genomic and transcriptomic approaches
RNA sequencing (RNA-seq) can reveal transcriptional changes in manganese transporters and related genes under conditions of manganese deficiency or overload. CRISPR screening combined with next-generation sequencing enables unbiased identification of genes that regulate manganese homeostasis, such as novel transporters or regulators. These methods are complemented by quantitative PCR and reporter assays to validate candidate hits.
Proteomic and metal analysis methods
Inductively coupled plasma mass spectrometry (ICP-MS) is the gold standard for measuring intracellular and organellar manganese concentrations. Proteomics can identify manganese-binding proteins and post-translational modifications induced by manganese imbalance. Fluorescent sensors, such as genetically encoded manganese indicators, allow real-time imaging of manganese dynamics in live cells.
Imaging and organellar studies
Confocal and electron microscopy can visualize manganese accumulation in organelles like the Golgi and mitochondria using manganese-sensitive dyes or genetically encoded sensors. Golgi pH and ion homeostasis can be assessed with pH-sensitive fluorophores, as manganese transport is coupled to Golgi pH. Mitochondrial function can be measured with Seahorse extracellular flux analysis to assess the impact of manganese on oxidative phosphorylation.
Functional assays for manganese transport
Transport assays using radioactive manganese (54Mn) or fluorescent manganese analogs can measure uptake and efflux kinetics in cells expressing wild-type or mutant transporters. Complementation assays in yeast or bacteria lacking endogenous manganese transporters can identify functional orthologs and assess the impact of disease mutations. These assays are essential for linking genotype to transport function.
How CRISPR Can Be Used to Study GO:0055071 manganese ion homeostasis
Knockout
CRISPR knockout (KO) of manganese homeostasis genes such as SLC30A10, SLC39A14, or ATP13A2 can model loss-of-function diseases and reveal their impact on cellular manganese levels. KO cell lines are valuable for studying manganese accumulation, oxidative stress, and organellar dysfunction. For example, SLC30A10 KO hepatocytes show increased manganese content and sensitivity to manganese-induced toxicity.
Point Mutation
CRISPR point mutation (base editing or HDR) can introduce disease-associated missense mutations, such as those in SLC39A8 or ATP13A2, to study their effects on transporter function and manganese homeostasis. These models are particularly useful for distinguishing pathogenic variants from benign polymorphisms. Point-mutation cell lines can be used in transport assays and structural studies.
Knock-in
CRISPR knock-in can be used to tag endogenous manganese transporters with fluorescent proteins or epitope tags, enabling real-time tracking of their localization and trafficking. Knock-in of patient mutations into a safe locus or the endogenous gene allows precise modeling of disease alleles. Tagged knock-in models are also useful for proteomic analysis of manganese transporter complexes.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase the expression of manganese transporters such as SLC30A10 or ATP13A2 to test whether enhanced efflux protects against manganese toxicity. Overexpression models are valuable for gain-of-function studies and for validating therapeutic targets. These approaches can be combined with manganese challenge assays to assess rescue of toxicity.
How EDITGENE Supports manganese ion homeostasis Research
Researchers studying manganese ion homeostasis-related genes often need to determine whether a candidate gene is causally involved in manganese transport, detoxification, or disease pathogenesis. CRISPR-based genome editing provides a precise way to create knockout, point-mutation, knock-in, and overexpression models that can be used to dissect gene function and validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for manganese ion homeostasis research.
Frequently Asked Questions About manganese ion homeostasis
What is manganese ion homeostasis?
Manganese ion homeostasis (GO:0055071) is the biological process that maintains a steady internal concentration of manganese ions within cells and organisms, balancing uptake, storage, utilization, and efflux.
What genes are involved in manganese ion homeostasis?
Key genes include SLC30A10, SLC39A8, SLC39A14, ATP13A2, ATP2C1, MTF1, and SOD2, which mediate manganese transport, sensing, and utilization.
Why is manganese important for health?
Manganese is an essential cofactor for enzymes like SOD2 and arginase, supporting antioxidant defense and metabolism, but both deficiency and overload can cause disease.
What diseases are linked to manganese dyshomeostasis?
Diseases include manganism, Parkinson's disease, Alzheimer's disease, hypermanganesemia with dystonia and cirrhosis, and congenital disorders of glycosylation.
How is manganese transported in cells?
Manganese enters cells via SLC39A8 and SLC39A14, is stored in the Golgi and mitochondria, and is exported by SLC30A10 and ATP13A2.
What is the role of the Golgi in manganese homeostasis?
The Golgi apparatus stores manganese and uses it for glycosylation enzymes; transporters like SPCA1 (ATP2C1) pump manganese into the Golgi lumen.
How can CRISPR be used to study manganese homeostasis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of manganese-related genes in transport and disease.
What methods measure manganese levels in cells?
ICP-MS, fluorescent manganese sensors, and radioactive 54Mn uptake assays are commonly used to quantify and track manganese.
Is manganese involved in neurodegeneration?
Yes, manganese overload accumulates in the basal ganglia and is associated with manganism and Parkinson-like syndromes.
What are the symptoms of manganese toxicity?
Symptoms include dystonia, parkinsonism, gait disturbances, and liver cirrhosis, often due to mutations in SLC30A10 or SLC39A14.
Conclusion
Manganese ion homeostasis (GO:0055071) is a fundamental biological process that ensures the proper balance of an essential yet potentially toxic metal. Its disruption is linked to a spectrum of human diseases, from neurodegenerative disorders to liver cirrhosis and congenital glycosylation defects. Advances in CRISPR genome editing and metal analysis technologies are enabling researchers to dissect the molecular mechanisms of manganese transport and regulation with unprecedented precision. Continued investigation of manganese homeostasis will likely yield new therapeutic strategies for metal-related diseases and deepen our understanding of cellular metal biology.
References
- 1. Jomova K et al.. 2022. Essential metals in health and disease.. Chem Biol Interact 367:110173 PMID: 36152810
- 2. Chen P et al.. 2018. Manganese metabolism in humans.. Front Biosci (Landmark Ed) 23(9):1655-1679 PMID: 29293455
- 3. Chen L et al.. 2025. Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.. Signal Transduct Target Ther 10(1):31 PMID: 39894843
- 4. Khosrowabadi E et al.. 2023. Golgi pH and Ion Homeostasis in Health and Disease.. Rev Physiol Biochem Pharmacol 185:1-23 PMID: 32870398
- 5. Li J et al.. 2022. Golgi Metal Ion Homeostasis in Human Health and Diseases.. Cells 11(2) PMID: 35053405
- 6. Su Z et al.. 2024. Biodegradable oxygen-evolving metalloantibiotics for spatiotemporal sono-metalloimmunotherapy against orthopaedic biofilm infections.. Nat Commun 15(1):8058 PMID: 39277594
- 7. Moore CM et al.. 2005. Metal ion homeostasis in Bacillus subtilis.. Curr Opin Microbiol 8(2):188-95 PMID: 15802251
- 8. Xiong Y et al.. 2022. All-in-One: Multifunctional Hydrogel Accelerates Oxidative Diabetic Wound Healing through Timed-Release of Exosome and Fibroblast Growth Factor.. Small 18(1):e2104229 PMID: 34791802
